Income StatementBalance SheetCash FlowSegments
Intel logo

Intel Cash Flow Statement

Operating, investing, and financing cash movements

Intel generated $10.0B in operating cash flow over the trailing twelve months. After $13.1B in capital expenditures, free cash flow was -$11.1B. Free cash flow increased 0.3% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)$10.0BNet Cash From Investing (TTM)-$11.8BNet Cash From Financing (TTM)$10.6BCapital Expenditures (TTM)$13.1BDepreciation And Amortization Cf (TTM)$10.3BNet Change In Cash (TTM)$8.7B
Latest FilingQ1 2026
Report Date2026-04-24
Market Cap$602.32B
ROE-3.01%

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Acquisitions, net of cash acquired$20.5M$0.0———$596.0M
Sales of short-term available-for-sale investments$10.4B$416.0M———$9.2B
Capital expenditures$5.8B$5.2B$3.6B$2.4B$3.5B$3.6B
Proceeds from capital grants$1.2B$803.0M$161.0M$54.0M$559.0M$107.0M
Proceeds from capital-related government incentives$1.2B$803.0M$161.0M$54.0M$559.0M$107.0M
Payment for (Proceeds from) Other Investing Activity$459.0M-$585.0M-$399.0M——$40.0M
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale—$4.9B$3.7B$2.4B—$5.2B
Sale of investments$10.4B$416.0M———$9.2B
Net cash from investing activities-$3.8B$81.0M-$2.1B-$6.3B-$6.6B$3.1B
Dividend Received from Consumer Healthcare JV$261.8M$167.8M$167.8M$167.8M$167.8M—
Proceeds from sale of businesses$0.0$1.9B—$4.3B—$0.0
Purchases of investments$6.4B$3.4B$2.3B$10.7B$7.9B$7.2B

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Proceeds from commercial paper notes$0.0$1.5B$2.0B——$0.0
Proceeds from Commercial Paper$0.0$1.5B$2.0B——$0.0
Proceeds from issuance of debt—$0.0$0.0$0.0$0.0—
Repayments of debt—$1.5B—$2.3B—$1.5B
Dividends paid$0.0$0.0$0.0$0.0$0.0—
Net proceeds from sales of subsidiary shares$0.0$230.3M$230.3M$230.3M$230.3M—
Proceeds from Issuance of Commercial Paper$0.0$1.5B$2.0B——$0.0
Net proceeds attributed to common stock and warrants issued, and Escrowed Shares$0.0$3.2B$3.2B$3.2B$3.2B—
Partner contributions—$955.0M$1.3B$1.4B—$2.1B
Other, net$694.0M-$618.0M-$60.0M-$374.0M—-$870.0M
Proceeds from issuance of common stock relating to employee stock plans$1.0M$491.0M—$286.0M—$427.0M
Repayment of commercial paper$9.0M——$2.0B——
Payments for PP&E (financing)$437.0M$1.0B$942.0M$531.0M$533.0M$1.3B
Payment of Deferred Purchase Consideration$694.0M-$618.0M-$60.0M-$374.0M—-$870.0M
Noncontrolling interest transactions and other$694.0M-$618.0M-$60.0M-$374.0M—-$870.0M
Net cash from financing activities$63.0M-$196.0M$782.0M$5.2B$5.8B-$1.2B
Noncontrolling Interests Activity and Other$694.0M-$618.0M-$60.0M-$374.0M—-$870.0M

Supplemental

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Capital expenditures incurred but not yet paid$1.5B$3.9B$1.2B——$1.9B
Recognition of capital-related government incentives—$985.0M$467.0M$4.6B—$639.0M
Interest paid—$635.0M—$642.0M—$600.0M
Capital expenditures incurred but not yet paid$1.5B$3.9B$1.2B——$1.9B
Capital Expenditures Incurred but Not Yet Paid$1.5B$3.9B$1.2B——$1.9B
Income Taxes Paid, Net$322.0M$221.0M$1.6B$146.0M—$261.0M

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Change in fair value of equity securities$61.5M$128.5M$128.5M$128.5M$128.5M—
Change in accounts payable$68.0M-$240.0M$354.0M-$395.0M$578.0M-$142.0M
Change in accounts receivable$357.0M-$414.0M-$590.0M$842.0M$611.0M$217.0M
Change in inventories$136.0M$83.0M-$182.0M$108.0M$129.0M$808.0M
Other working capital changes-$2.2B$1.2B$536.0M——$1.3B
Deferred income taxes$0.0$19.0M$87.0M$17.0M$205.0M-$9.0M
Change in fair value of equity securities$61.5M$128.5M$128.5M$128.5M$128.5M—
Other operating reconciliation adjustments$3.3B$1.7B$5.1B—$4.6B$5.4B
Restructuring and other charges$57.0M$0.0$382.0M$0.0$104.0M$4.0B
Net cash from operating activities$3.2B$813.0M$2.1B$2.5B$4.3B$1.1B
Net income-$153.0M-$887.0M-$3.0B$4.3B-$591.0M-$4.3B
Amortization of capitalized software and acquired intangible assets$347.0M$249.0M$225.0M$234.0M$241.0M$234.0M
Depreciation$2.3B$2.4B$2.8B$2.8B$2.8B$2.9B
Accrued compensation and employee benefits-$1.6B-$741.0M$1.8B—$247.0M-$1.2B
Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable—$67.0M-$1.4B——$169.0M
NonCash Gains (Losses) On Equity Investments, Net—-$112.0M$502.0M$221.0M—-$72.0M
Gain (loss) on mark-to-market of Escrowed Shares$0.0$0.0——-$109.0M-$1.1B
Stock-based compensation$651.0M$684.0M$664.0M$548.0M$538.0M$621.0M
Adjustments to Reconcile Net Income to Operating Cash Flow$3.3B$1.7B$5.1B—$4.6B$5.4B

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow-$2.7B-$4.4B-$1.5B——-$2.5B

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Net increase (decrease) in cash—$698.0M$746.0M$1.4B$3.6B$3.0B
Accrued payables for capital expenditures$1.5B$3.9B$1.2B——$1.9B